DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Zim Laboratories Limited (ZIMLAB) share price today?

Zim Laboratories Limited (ZIMLAB) is trading at ₹146.02 on the NSE, up 4.08% on the day. Source: DocStoX.

What is the PE ratio of Zim Laboratories Limited?

Zim Laboratories Limited has a price-to-earnings (PE) ratio of 122.7 in the Healthcare sector.

What is the market capitalisation of Zim Laboratories Limited?

Zim Laboratories Limited has a market capitalisation of approximately ₹780 crore.

Is Zim Laboratories Limited a profitable company?

Zim Laboratories Limited generates a return on equity of 2.0% with a net profit margin of 1.6%. That is a modest return on shareholder capital.

What is the 52-week high and low of ZIMLAB?

Zim Laboratories Limited (ZIMLAB) has traded between ₹59.31 and ₹159.81 over the past 52 weeks, against a current price of ₹146.02.

Zim Laboratories Limited

₹146.02▲ +5.72 (+4.08%)

ZIMLAB·NSE·Healthcare

Market Cap

779.66 Cr

PE Ratio

122.71

Volume

1,56,059

Day High - Low

148.00 - 138.50

52W High-Low

159.81 - 59.31

₹146.02▲ +5.72 (+4.08%)

Market Cap779.66 Cr

PE Ratio122.71

Volume1,56,059

Day High - Low148.00 - 138.50

52W High-Low159.81 - 59.31

Zim Laboratories Limited (ZIMLAB): company summary

The company's business is shrinking, with annual revenue falling 1.2% and net profit dropping 51.3%.

Zim Laboratories Limited (ZIMLAB) is a micro-cap Healthcare company valued at ₹780 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move: Zim Laboratories Limited last traded at ₹146.02, up 4.08% on the day.
Recent developments: On 2026-09-18, Zim Laboratories Limited announced an update regarding the acquisition of 'to be incorporated companies' through XBRL, indicating a potential expansion or restructuring effort.
Financial performance: The company's business is shrinking, with annual revenue falling 1.2% and net profit dropping 51.3%. The latest quarter saw revenue rise 31.2% compared to the same quarter a year earlier, but net profit worsened from a loss of ₹2 crore to a loss of ₹4 crore.
Valuation multiples: The stock trades at 122.7 times earnings, a premium to the Healthcare median of 32.0, 2.50 times book value.
Things to watch: The company's net profit margin has narrowed by 1.6 percentage points to 1.6%, and its latest quarter net profit widened to a loss of ₹4 crore. The stock is 5.2% below its 52-week high, and the company has not paid dividends despite reporting profits.
Where it stands: Zim Laboratories Limited is facing declining profitability, with annual net profit falling 51.3% and a recent quarterly loss of ₹4 crore. The stock is 5.2% below its 52-week high, and the company has not distributed dividends despite reporting profits.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score

3.6/10

Poor

Fair Value

ROE

1.97%

Weak

P/E

122.71x

Expensive

Debt / Equity

0.42

Moderate

Industry

Healthcare

Pharmaceuticals

Overall View

Mixed

Price performance

Day₹138.50

₹148.00

52W₹59.31

₹159.81

DocStoX take

Supported by risk (7.6) and momentum (7.5), but held back by valuation (0.0). Risk looks strong at 7.6, but that is offset by valuation at 0.0 and growth at 1.4. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence

3.6

/10

Poor

Quality

Modest

ROE 2.0%

Valuation

Expensive

P/E 122.7×

Growth

Flat

Revenue +4.0% 5Y CAGR

Risk

Low risk

D/E 0.42

Momentum

Strong

86% of 52-week range

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹146

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹780 Cr

52W High / Low

₹160 / ₹59

Dividend Yield

0.00%

Promoter Holding

30.30%

EPS (TTM)

₹1.19

Book Value

₹55.36

Key highlights

Profitable in all of the last 5 years
Profit shrinking 4% a year
Valuation is weak (0.0/10)

1 Positive4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Explore Zim Laboratories Limited’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Zim Laboratories Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Laurus Labs Limited Cipla Limited Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited Mankind Pharma Limited Lupin Limited Manipal Health Enterprises Limited

Compare Zim Laboratories Limited with peers

Zim Laboratories Limited vs Sun Pharmaceutical Industries Limited Zim Laboratories Limited vs Divi's Laboratories Limited Zim Laboratories Limited vs Torrent Pharmaceuticals Limited Zim Laboratories Limited vs Apollo Hospitals Enterprise Limited Zim Laboratories Limited vs Zydus Lifesciences Limited Zim Laboratories Limited vs Laurus Labs Limited

Related tools & concepts

Value Zim Laboratories Limited with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

ZIMLAB newsLatest coverage & filings Open screenerFilter the whole market